Paratek Pharmaceuticals, Inc. promoted Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer. Light, who joined Paratek in 2017, has over 20 years of corporate, legal, regulatory and compliance experience and has played a pivotal role in key milestones for the company, including the launch and ongoing commercialization of NUZYRA and the company?s recent take-private transaction with Gurnet Point Capital and Novo Holdings A/S. Light joined Paratek from Teva Pharmaceuticals, where he served as Executive Counsel providing guidance to leadership on key corporate and regulatory compliance matters for the company?s oncology, respiratory and biologics business units in addition to supporting business development, litigation and multiple product launches. Light was also previously an in-house attorney at Shire Pharmaceuticals, where he counseled the company?s GI business unit on a range of matters including commercial operations, and sales and marketing activities.

He started his legal career as a litigator at Morgan Lewis, where he handled complex commercial disputes, government investigations and product liability matters for several leading life sciences companies. Light received a Bachelor of Arts from Dartmouth College and a Juris Doctor from the University of Virginia School of Law.